Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Blood Dialyzer Market Insights
The process of hemodialysis remains the popular renal replacement therapy in most countries, worldwide. During the last decade, there has been an increasing interest in understanding the needs of hemodialysis patients. Various risk factors, such as failures, adverse reactions, and poor outcomes of older dialysis methods are setting path for higher demand for blood dialyzers, thus propelling the overall market growth.
Blood dialyzers, also called hemodialyzer, are mainly used for the removal of excess fluid accumulated in kidney. Excess fluid is removed by creating a pressure gradient across two compartments of dialyzer. Three primary methods commonly used to gain access to the blood during hemodialysis are: intravenous catheter, arteriovenous fistula (AV), and synthetic graft. The type of access to these methods is determined by factors such as the expected time course of a patient's renal failure and the condition of vasculature of patient.
The global blood dialyzer market size was valued at US$ 4,682.7 million in 2017, and is expected to witness a CAGR of 6.1% during the forecast period (2018 – 2026).
Figure 1. Global Blood dialyzer Market value Analysis (US$ Mn) and Forecast and Absolute $ Opportunity
Source: Coherent Market Insights Analysis
Rising Global Burden of Kidney Diseases is expected to Drive Growth of the Blood Dialyzer Market
Global burden of kidney diseases, which have direct impact on global morbidity and mortality rate is continuously rising and in turn fuels growth of the blood analyzer market. For instance, the Global Burden of Disease (GBD) 2015 study, estimated that 1.2 million people died from kidney failure in 2005-2015, an increase of 32% since 2005. Additionally, overall, an estimated 5–10 million people die annually, from kidney disease.
Furthermore, kidney disease is associated with a tremendous economic burden. GBD 2015 study states, high-income countries typically spend over 2–3% of the annual health-care budget on the treatment of end-stage kidney diseases, which is expected to favor the blood dialyzer market.
Moreover, significant increase in the number of U.S. Food and Drug Administration (USFDA) approvals for blood dialyzers will aid in growth of the market. For instance, in June 2018, USFDA permitted marketing of two catheter-based dialyzers, Ellipsys Vascular Access system and everlinQ endoAVF system, which are designed to create a connection to veins and arteries in patients with chronic kidney disease who need hemodialysis. Such approvals are positively impacting the overall market growth.
Nevertheless, lack of meeting regulatory standards is leading to product recalls, which is likely to inhibit growth of blood dialyzers in the global market.
For instance, in February 2014, government of Canada recalled Optiflux Hemodialyzer and Optiflux Capillary Dialyzers, manufactured by Fresenius Medical Care, due to leakage in the dialyzer product.
Blood Dialyzer Market- Regional Analysis
Regional segmentation of the global blood dialyzer market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America holds the major share due to innovative and new initiatives of key players focusing chronic kidney disease and dialysis. For instance, in April 2018, CVS Health, U.S., took a new initiative, focusing on early identification of kidney disease and awareness for home dialysis systems. As part of this initiative, CVS Health started a pivotal clinical trial to demonstrate the safety and efficacy of a new home hemodialysis device in order to obtain market clearance from FDA.
Asia Pacific is expected to witness significant growth in the global blood dialyzer market, owing to increasing patient pool and growing medical tourism for various surgeries in the region. For instance, according to Directorate-General of Commercial Intelligence and Statistics of India, in 2015-2016, hospitals in India recorded 460,000 international patients.
Moreover, NephroPlus, India’s largest dialysis service provider, successfully achieved a significant milestone in the dialysis sector by completing 2 million dialysis sessions in India in March 2018. The company is offering dialysis solutions at affordable prices in India and this low-cost model is expected to increase medical tourism in India and can propel growth of blood dialyzers in the global market.
Figure 2: Global Blood Dialyzer Market Value (US$ Mn), By Region
Source: Coherent Market Insights Analysis
Blood Dialyzer Market- Competitive Landscape
Key players operating in the blood dialyzer market include Baxter International, Inc., Nikkiso Co. Ltd., B. Braun Medical Inc., Nipro Corporation, CVS Health., Diaverum Deutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, and DaVita Healthcare Partners, Inc.